首页|基于真实世界的养阴舒肝方治疗早发性卵巢功能不全的临床疗效研究

基于真实世界的养阴舒肝方治疗早发性卵巢功能不全的临床疗效研究

扫码查看
目的 基于真实世界数据,研究养阴舒肝方治疗早发性卵巢功能不全(POI)肾虚肝郁证的临床疗效与安全性。方法 收集2020 年1 月—2023 年12 月广东省中医院门诊病历系统登记的POI肾虚肝郁证患者618 例,经1∶1 倾向性匹配,纳入符合研究标准的POI患者222 例,分成养阴舒肝方组(仅服用养阴舒肝方)及激素组(仅服用激素),每组各 111 例。记录并比较 2 组患者年龄、初潮年龄、婚姻状况、病程、妊娠次数、流产次数、月经总分、中医证候总分、基础血清卵泡刺激素(bFSH)、抗米勒管激素(AMH)。治疗3~4 个月后,比较2 组患者中医证候、月经及 bFSH疗效、随访期(停药后3 个月)月经复常率,治疗前后 2 组中医证候总分及各症状评分、月经总分及各项评分、bFSH、AMH。结果 ①养阴舒肝方组、激素组中医证候总有效率分别为 85。59%、52。25%;月经总有效率分别为54。95%、90。99%;随访期月经复常率分别为 31。53%、9。01%;bFSH总有效率分别为70。27%、27。03%,bFSH复常率分别为35。14%、9。01%。以上指标2 组间比较,差异均具有统计学意义(P<0。01)。②治疗后,养阴舒肝方组bFSH值较治疗前下降(P<0。01),激素组治疗前后差异无统计学意义;养阴舒肝方组AMH值较治疗前上升(P<0。01),激素组治疗前后差异无统计学意义。2 组治疗后比较,差异均具有统计学意义(P<0。01)。③养阴舒肝方组治疗后中医证候总分及各症状评分均较治疗前下降(P<0。01);激素组治疗后中医证候总分及烘热汗出、性欲减退、失眠评分较治疗前下降(P<0。01)。治疗后,养阴舒肝方组中医证候总分及各症状评分均低于激素组(P<0。01)。④养阴舒肝方组治疗后月经总分及周期、经期、经量、经色评分均较治疗前下降(P<0。01);激素组治疗后月经总分及周期、经期、经量评分均较治疗前下降(P<0。01);治疗后,激素组月经总分及周期评分优于养阴舒肝方组(P<0。01)。⑤养阴舒肝方组未见不良反应,激素组不良反应29 例。结论 养阴舒肝方可有效改善POI肾虚肝郁证患者的中医证候,下调POI患者bFSH水平、上调AMH水平,有效改善卵巢功能,在停药后仍可维持月经。真实世界中,养阴舒肝方治疗POI肾虚肝郁证患者疗效满意、安全性好,值得临床推广应用。
A clinical efficacy study of Yangyin Shugan Decoction to treat premature ovarian insufficiency based on real-world evidence
Objective Based on the real-world data,we aimed to study the clinical efficacy and safety of Yangyin Shugan(method of nourishing yin and soothing liver)Decoction,an empirical prescription of famous traditional Chinese medicine(TCM)practitioners,in the treatment of premature ovarian insufficiency(POI)with pattern of kidney deficiency and liver depression.Methods A total of 618 POI patients with pattern of kidney deficiency and liver depression who registered in the outpatient electronic medical record system of Guangdong Provincial Hospital of Chinese Medicine were collected from January 2020 to December 2023.After 1:1 propensity matching,a total of 222 patients with POI who met the criteria were included and assigned to a Yangyin Shugan Decoction group(treated with Yangyin Shugan Decoction only)and a hormone control group(hormone treatment only),with 111 cases in each group.Age,age at menarche,marriage status,duration,times of pregnancy,times of miscarriage,menstrual total score,total score of TCM syndrome,basal serum follicle-stimulating hormone(bFSH),and anti-Müllerian hormone(AMH)were recorded and compared.After 3 to 4 months of treatment,the clinical efficacy between the two groups include TCM syndromes,menstrual,bFSH,and menstrual normalization rates during the follow-up period(3 months after discontinuation of medication)were compared.Additionally,comparisons were also made before and after treatment for the total score of TCM syndrome and scores of individual symptom,menstrual total score and scores of indicator,bFSH level,and AMH levels in both groups.Results(ⅰ)The total effective rate of the TCM syndrome in the Yangyin Shugan Decoction group and hormone control group were 85.59%and 52.25%,respectively;the total effective rate of menstrual were 54.95%and 90.99%,respectively;the menstrual normalization rate during the follow-up period were 31.53%and 9.01%,respectively;and regarding bFSH efficacy,the total effective rate were 70.27%and 27.03%,respectively,and the normalization rate of bFSH were 35.14%and 9.01%,respectively.The differences between the two groups were statistically significant(P<0.01).(ⅱ)The bFSH value in the Yangyin Shugan Decoction group decreased after treatment compared to before treatment(P<0.01),while the bFSH value in the hormone control group showed no change before and after treatment.The AMH value increased after treatment compared to before treatment in Yangyin Shugan Decoction group(P<0.01),while the AMH value in the hormone control group showed no change before and after treatment.The difference of bFSH and AMH between the two groups after treatment was statistically significant(P<0.01).(ⅲ)After treatment,the total score of TCM syndrome and the scores of individual symptom in the Yangyin Shugan Decoction group were lower than those before treatment(P<0.01);the total score of TCM syndrome,scores of hot flushes and sweating,hyposexuality,and insomnia in the hormone control group were lower than those before treatment(P<0.01).After treatment,the total score of TCM syndrome and the scores of individual symptom in the Yangyin Shugan Decoction group were lower than those in the hormone control group(P<0.01).(ⅳ)After treatment,the menstrual total score,scores of menstrual cycle,period,menstrual flow,and menstrual blood color in the Yangyin Shugan Decoction group were lower than those before treatment(P<0.01);the menstrual total score,score of menstrual cycle,period,and menstrual flow in the hormone control group were lower than those before treatment(P<0.01);after treatment,the menstrual total score and menstrual cycle score in the hormone control group were better than those in the Yangyin Shugan Decoction group(P<0.01).(ⅴ)No adverse reactions were observed in the Yangyin Shugan Decoction group and 29 cases of adverse reactions were observed in the hormone control group.Conclusion Yangyin Shugan Decoction can effectively improve TCM syndrome in POI patients with pattern of kidney deficiency and liver depression;downregulate the elevated bFSH level,increase the low AMH level,and effectively improve ovarian function,even continue to maintain menstruation after drug withdrawal.In the real world,Yangyin Shugan Decoction got satisfactory efficacy and good safety in the treatment of POI,which deserves clinical promotion and application.

premature ovarian insufficiencyYangyin Shugan Decoctionpattern of kidney deficiency and liver depressionreal worldretrospective study

黄旭春、李灵通、侯佳睿、梁娜、曹晓静、成芳平、老膺荣、王小云

展开 >

广州中医药大学第二临床医学院 广州 510120

广州中医药大学

早发性卵巢功能不全 养阴舒肝方 肾虚肝郁证 真实世界 回顾性研究

2024

北京中医药大学学报
北京中医药大学

北京中医药大学学报

CSTPCD北大核心
影响因子:1.568
ISSN:1006-2157
年,卷(期):2024.47(12)